U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H7NO2
Molecular Weight 137.136
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANTHRANILIC ACID

SMILES

NC1=CC=CC=C1C(O)=O

InChI

InChIKey=RWZYAGGXGHYGMB-UHFFFAOYSA-N
InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)

HIDE SMILES / InChI

Molecular Formula C7H7NO2
Molecular Weight 137.136
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: DOI: 10.2174/157017906777934926 | https://www.ncbi.nlm.nih.gov/pubmed/12844171

Sodium anthranilate is an excipient (pharmacologically inactive substance). Sodium anthranilate (Aminobenzoate sodium ,C7H6NNaO2), also known as sodium 2-aminobenzoate, is an organic amine. Aminobenzoate sodium exists as a yellow powder for use in pharmaceutical processing.

Originator

Sources: DOI: 10.2174/157017906777934926

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Desoxyn

Approved Use

Desoxyn is used in the treatment of adhd; obesity and belongs to the drug classes anorexiants, CNS stimulants.

Launch Date

1943
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Production and analysis of organic acids in hairy-root cultures of Isatis indigotica Fort. (indigo woad).
2004-02
Probing cathepsin K activity with a selective substrate spanning its active site.
2003-10-15
Waste-free and facile solid-state protection of diamines, anthranilic acid, diols, and polyols with phenylboronic acid.
2003-09-05
A concise total synthesis of (+/-)-alantrypinone by a novel hetero-Diels-Alder reaction.
2003-09-04
Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.
2003-08-01
S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.
2003-08-01
Gene cluster of Arthrobacter ilicis Ru61a involved in the degradation of quinaldine to anthranilate: characterization and functional expression of the quinaldine 4-oxidase qoxLMS genes.
2003-07-25
Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.
2003-07-01
A quasi-tetrahedral Cu4 cluster and a helical-chain copper (II) complex with single syn-anti carboxylate bridges: crystal structure and magnetic properties.
2003-06-30
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs.
2003-05-19
Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.
2003-05-01
Complexity of coordinative bonding in thallium(I) anthranilates and salicylates.
2003-03-26
Conjugate additions of o-iodoanilines and methyl anthranilates to acetylenic sulfones. A new route to quinolones including first syntheses of two alkaloids from the medicinal herb Ruta chalepensis.
2003-03-21
Anthranilic acid derivatives: a new class of non-peptide CCK1 receptor antagonists.
2003-03-06
Separation of saccharides derivatized with 2-aminobenzoic acid by capillary electrophoresis and their structural consideration by nuclear magnetic resonance.
2003-03-01
Construction and complementation of the first auxotrophic mutant in the spirochaete Leptospira meyeri.
2003-03
Glucose conjugation of anthranilate by the Arabidopsis UGT74F2 glucosyltransferase is required for tryptophan mutant blue fluorescence.
2003-02-21
Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
2003-02-10
High-performance liquid chromatography assay for 1-deoxy-D-xylulose 5-phosphate synthase activity using fluorescence detection.
2003-02-07
Complete nucleotide sequence of carbazole/dioxin-degrading plasmid pCAR1 in Pseudomonas resinovorans strain CA10 indicates its mosaicity and the presence of large catabolic transposon Tn4676.
2003-02-07
Avenanthramides in oats (Avena sativa L.) and structure-antioxidant activity relationships.
2003-01-29
Total synthesis of (-)-fumiquinazolines A, B, C, E, H, and I. Approaches to the synthesis of fiscalin A.
2003-01-24
Kynurenines and the respiratory parameters on rat heart mitochondria.
2003-01-24
Peptides to peptidomimetics: towards the design and synthesis of bioavailable inhibitors of oligosaccharyl transferase.
2003-01-07
Allergic contact dermatitis from etofenamate without cross-sensitization to other anthranilic acid derivatives.
2003
Lateral gene transfer and ancient paralogy of operons containing redundant copies of tryptophan-pathway genes in Xylella species and in heterocystous cyanobacteria.
2003
Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors.
2002-12-19
Ortho-aminobenzoic acid-labeled bradykinins in interaction with lipid vesicles: fluorescence study.
2002-12-05
Location of abasic sites in oligodeoxynucleotides by tandem mass spectrometry and by a chemical cleavage initiated by an unusual reaction of the ODN with MALDI matrix.
2002-12
Yeast D-amino acid oxidase: structural basis of its catalytic properties.
2002-11-29
Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides.
2002-11-15
Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-phenyl-3-substituted quinazolin-4(3H) ones.
2002-11
An improved synthesis of 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
2002-10
Temperature and salts effects on the peptidase activities of the recombinant metallooligopeptidases neurolysin and thimet oligopeptidase.
2002-09
Dynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a novel operon for tryptophan recapture.
2002-08-29
Newer N-substituted anthranilic acid derivatives as potent anti-inflammatory agents.
2002-08
The crystal structure of anthranilate phosphoribosyltransferase from the enterobacterium Pectobacterium carotovorum.
2002-07-17
Modification of carbon nanofibres for the immobilization of metal complexes: a case study with rhodium and anthranilic acid.
2002-07-02
Role of rhizobial biosynthetic pathways of amino acids, nucleotide bases and vitamins in symbiosis.
2002-07
Characterization of Trp(+) reversions in Escherichia coli strain WP2uvrA.
2002-07
Biosynthesis of nodulisporic acid A: precursor studies.
2002-06-19
Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting.
2002-06-01
[Structural variation of o-amino-benzoic acid induced by free electron laser].
2002-06
Effects of fatty liver induced by niacin-free diet with orotic acid on the metabolism of tryptophan to niacin in rats.
2002-06
Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
2002-05
Photocyclization of N,N-phthaloylanthranilic amides coupled to omega-amino acids with increasing chain lengths.
2002-04
Tranilast slows the progression of advanced diabetic nephropathy.
2002
Update on sensitivity to nonsteroidal antiinflammatory drugs.
2001-11
Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
2001
Research on tryptophan metabolites "via kynurenine" in epidermis of man and mouse.
1975
Patents

Sample Use Guides

15,000 or 30,000 ppm for the rats, and either 25,000 or 50,000 ppm for the mice, 5 days per week for 78 weeks
Route of Administration: Oral
The DNA damage effects of tryptophan metabolites were analyzed using plasmid relaxation assay performed with anthranilic acid at various concentrations between 50 uM and 400 uM in the presence of plasmid DNA pSP-72. Anthranilic acid did not show any plasmid relaxation activity.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:44:44 GMT 2025
Edited
by admin
on Mon Mar 31 18:44:44 GMT 2025
Record UNII
0YS975XI6W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
O-AMINOBENZOIC ACID
MI  
Preferred Name English
ANTHRANILIC ACID
HSDB   WHO-DD  
Systematic Name English
NSC-40929
Code English
Anthranilic acid [WHO-DD]
Common Name English
NSC-144
Code English
VITAMIN L1
Common Name English
NCI-C01730
Code English
ANTHRANILIC ACID [HSDB]
Common Name English
BENZOIC ACID, 2-AMINO-
Common Name English
2-AMINOBENZOIC ACID
Systematic Name English
O-CARBOXYANILINE
Common Name English
BENZOIC ACID, O-AMINO-
Common Name English
ANTHRANILIC ACID [IARC]
Common Name English
O-ANTHRANILIC ACID
Common Name English
O-AMINOBENZOIC ACID [MI]
Common Name English
1-AMINO-2-CARBOXYBENZENE
Systematic Name English
2-CARBOXYANILINE
Systematic Name English
Classification Tree Code System Code
DEA NO. 8530
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
Code System Code Type Description
MESH
C031385
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
SMS_ID
100000077403
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
HSDB
1321
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
CHEBI
30754
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
FDA UNII
0YS975XI6W
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
CAS
118-92-3
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
PUBCHEM
227
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
EVMPD
SUB12908MIG
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
NSC
144
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
EPA CompTox
DTXSID8020094
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
WIKIPEDIA
ANTHRANILIC ACID
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
NSC
40929
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
MERCK INDEX
m1687
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
204-287-5
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
DRUG BANK
DB04166
Created by admin on Mon Mar 31 18:44:44 GMT 2025 , Edited by admin on Mon Mar 31 18:44:44 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT